Evidence map›Paper›PMID 30552204›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2019

Ayoung Pyo, Hyeon Sik Kim, Hyung Seok Kim, Misun Yun, Dong-Yeon Kim, Jung-Joon Min

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Development ofEuropean journal of nuclear medicine and molecular imaging · 2025
    Article
  2. Article
  3. KSNM60: The History of Radiopharmaceutical Sciences in Korea.Nuclear medicine and molecular imaging · 2022
    Review
  4. Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ayoung PyoDepartment of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun, Korea.
Hyeon Sik KimDepartment of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun, Korea.
Hyung Seok KimDepartment of Forensic Medicine, Chonnam National University Medical School, Hwasun, Korea; and.
Misun YunMicrobiology and Functionality Research Group, Research and Development Division, World Institute of Kimchi, Gwangju, Korea.
Dong-Yeon KimDepartment of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun, Korea jjmin@jnu.ac.kr blueburr@gmail.com.
Jung-Joon MinDepartment of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun, Korea jjmin@jnu.ac.kr blueburr@gmail.com.
Chonnam National University Hwasun Hospital · KRWorld Institute of Kimchi · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant melanoma is an aggressive and serious form of skin cancer, with prognosis and treatment outcome depending heavily on the clinical stage of the disease at the time of diagnosis. Here, we synthesized a novel

Indexed as

AnimalsBenzamidesBiological TransportCell Line, TumorDrug StabilityHumansMelanomaMiceMolecular ProbesNeoplasm MetastasisPositron-Emission TomographySkin NeoplasmsTissue DistributionBenzamidesMolecular Probes18F-labeled benzamide derivativemalignant melanomametastasismolecular imagingPET

Identifiers

PMID30552204
PMCPMC6604686
OpenAlexW2904113371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.